{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:26:17Z","timestamp":1773411977093,"version":"3.50.1"},"reference-count":24,"publisher":"Japan Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1507\/endocrj.ej14-0097","type":"journal-article","created":{"date-parts":[[2014,5,19]],"date-time":"2014-05-19T22:56:56Z","timestamp":1400540216000},"page":"773-779","source":"Crossref","is-referenced-by-count":6,"title":["Desmopressin orally disintegrating tablet in Japanese patients with central diabetes insipidus: A retrospective study of switching from intranasal desmopressin"],"prefix":"10.1507","volume":"61","author":[{"given":"Takaaki","family":"Murakami","sequence":"first","affiliation":[{"name":"Department of Diabetes and Endocrinology, Osaka Red Cross Hospital, Osaka 543-0027, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonobu","family":"Hatoko","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Osaka Red Cross Hospital, Osaka 543-0027, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuo","family":"Nambu","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Osaka Red Cross Hospital, Osaka 543-0027, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Osaka Red Cross Hospital, Osaka 543-0027, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Osaka Red Cross Hospital, Osaka 543-0027, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Yonemitsu","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Osaka Red Cross Hospital, Osaka 543-0027, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Muro","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Osaka Red Cross Hospital, Osaka 543-0027, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Oki","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Osaka Red Cross Hospital, Osaka 543-0027, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Heinbecker P, White HL (1939) The role of the pituitary gland in water balance. <i>Ann Surg<\/i> 110: 1037-1049.","DOI":"10.1097\/00000658-193912000-00004"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Vilhardt H, Bie P (1984) Antidiuretic effect of perorally administered DDAVP in hydrated humans. <i>Acta Endocrinol (Copenh)<\/i> 105: 474-476.","DOI":"10.1530\/acta.0.1050474"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Williams TD, Dunger DB, Lyon CC, Lewis RJ, Taylor F, et al. (1986) Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children. <i>J Clin Endocrinol Metab<\/i> 63: 129-132.","DOI":"10.1210\/jcem-63-1-129"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. d&rsquo;Agay-Abensour L, Fjellestad-Paulsen A, H&ouml;glund P, Ng&ocirc; Y, Paulsen O, et al. (1993) Absolute bioavailability of an aqueous solution of 1-deamino-8-D-arginine vasopressin from different regions of the gastrointestinal tract in man. <i>Eur J Clin Pharmacol<\/i> 44: 473-476.","DOI":"10.1007\/BF00315546"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Westgren U, Wittstr&ouml;m C, Harris AS (1986) Oral desmopressin in central diabetes insipidus. <i>Arch Dis Child<\/i> 61: 247-250.","DOI":"10.1136\/adc.61.3.247"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fjellestad A, Czernichow P (1986) Central diabetes insipidus in children. V. Oral treatment with a vasopressin hormone analogue (DDAVP). <i>Acta Paediatr Scand<\/i> 75: 605-610.","DOI":"10.1111\/j.1651-2227.1986.tb10259.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Weiss JP, Zinner NR, Klein BM, N&oslash;rgaard JP (2012) Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial. <i>Neurourol Urodyn<\/i> 31: 441-447.","DOI":"10.1002\/nau.22243"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Fukuda I, Hizuka N, Takano K (2003) Oral DDAVP is a good alternative therapy for patients with central diabetes insipidus: experience of five-year treatment. <i>Endocr J<\/i> 50: 437-443.","DOI":"10.1507\/endocrj.50.437"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Arima H, Oiso Y, Juul KV, N&oslash;rgaard JP (2013) Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study. <i>Endocr J <\/i>60: 1085-1094.","DOI":"10.1507\/endocrj.EJ13-0165"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Miller M, Dalakos T, Moses AM, Fellerman H, Streeten DH (1970) Recognition of partial defects in antidiuretic hormone secretion. <i>Ann Intern Med<\/i> 73: 721-729.","DOI":"10.7326\/0003-4819-73-5-721"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zerbe RL, Robertson GL (1981) A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. <i>N Engl J Med<\/i> 305: 1539-1546.","DOI":"10.1056\/NEJM198112243052601"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fenske W, Allolio B (2012) Clinical review: Current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review.<i> J Clin Endocrinol Metab <\/i>97: 3426-3437.","DOI":"10.1210\/jc.2012-1981"},{"key":"13","unstructured":"13. Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (2011) Williams Textbook of Endocrinology.12th Ed. Saunders, Philadelphia, USA: 296-298."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Oiso Y, Iwasaki Y, Yamauchi K, Takatsuki K, Tomita A, et al. (1986) Clinical assessment of posterior pituitary function by direct measurement of plasma vasopressin levels during hypertonic saline infusion. <i>Folia endocrinol<\/i> 62: 608-618 (In Japanese).","DOI":"10.1507\/endocrine1927.62.5_608"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Richardson DW, Robinson AG (1985) Desmopressin. <i>Ann Intern Med<\/i> 103: 228-239.","DOI":"10.7326\/0003-4819-103-2-228"},{"key":"16","unstructured":"16. Kim RJ, Malattia C, Allen M, Moshang T Jr, Maghnie M (2004) Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations. <i>Pediatr Endocrinol Rev<\/i> 2 Suppl 1: 115-123."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Singer I, Oster JR, Fishman LM (1997) The management of diabetes insipidus in adults. <i>Arch Intern Med<\/i> 157: 1293-1301.","DOI":"10.1001\/archinte.1997.00440330027003"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Westgren U, Wittstr&ouml;m C, Harris AS (1986) Oral desmopressin in central diabetes insipidus. <i>Arch Dis Child<\/i> 61: 247-250.","DOI":"10.1136\/adc.61.3.247"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Vande Walle J, Stockner M, Raes A, N&oslash;rgaard JP (2007) Desmopressin 30 years in clinical use: a safety review. <i>Curr Drug Saf<\/i> 2: 232-238.","DOI":"10.2174\/157488607781668891"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Harris AS1, Hedner P, Vilhardt H (1987) Nasal administration of desmopressin by spray and drops. <i>J Pharm Pharmacol<\/i> 39: 932-934.","DOI":"10.1111\/j.2042-7158.1987.tb03131.x"},{"key":"21","unstructured":"21. Terano T, Yoshida S, Hibi T (1996) Clinical Evaluation of Desmopressin acetate nasal spray (KW-8008) in Patients with Diabetes Insipidus. <i>Horumon to Rinsho <\/i>(<i>Clinical Endocrinology<\/i>) 44, 89-99 (In Japanese) ."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hammer M, Vilhardt H (1985) Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin.<i> J Pharmacol Exp Ther <\/i>234: 754-760.","DOI":"10.1016\/S0022-3565(25)23723-5"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Robson WL, Leung AK, Norgaard JP (2007) The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis. <i>J Urol<\/i> 178: 24-30.","DOI":"10.1016\/j.juro.2007.03.015"},{"key":"24","unstructured":"24. The Group of diencephalohypophysial dysfunction of Research on Measures for Intractable Diseases of Japan&rsquo;s Ministry of Health, Labour and Welfare (2010) The report of Research on Measures for Intractable Diseases of Japan&rsquo;s Ministry of Health, Labour and Welfare. 153-157 (In Japanese)."}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/61\/8\/61_EJ14-0097\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T23:43:12Z","timestamp":1746229392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/61\/8\/61_EJ14-0097\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej14-0097","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}